This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Discussing Medtronic's FDA-cleared MiniMed™ Go Smart MDI system with Abbott Instinct sensor and its role in the evolving diabetes treatment landscape

Ticker(s): MDT, ABT

Who's the expert?

Institution: Luminis Health

  • Endocrinologist at Luminis Health in Annapolis, MD
  • Treats over 900 patients per year with obesity.
  • KOL and research expert on MC4R Agonist's an other pathways to addressing obesity. 

Interview Goal
On this call, we will talk in details on the MiniMed Go™ system - a smart diabetes management solution that uses the InPen™ smart insulin pen and the Instinct sensor made by Abbott through the MiniMed Go app and how it can be used for type 1 and type 2 diabetes aged 7 years and older, as well as for children ages 2 to 6 years under supervision.

Are You Interested In These Questions?

Slingshot Insights Explained
16Days Left to Join Project

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.